Press release
Investigation for Long-Term Investors in shares of CareDx, Inc (NASDAQ: CDNA) over possible Wrongdoing
An investigation on behalf of investors in CareDx, Inc (NASDAQ: CDNA) shares over potential wrongdoing at CareDx, Inc.
Investors who purchased shares of CareDx, Inc (NASDAQ: CDNA) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain CareDx, Inc directors breached their fiduciary duties and caused damage to the company and its shareholders.
Brisbane, CA based CareDx, Inc., a transplant diagnostics company, together with its subsidiaries, focuses on the discovery, development, and commercialization of diagnostic solutions for transplant patients worldwide.
On January 25, 2021, CareDx, Inc sold 1,923,077 shares of its common stock through an underwritten public offering at a public offering price of $91.00 per share.
On October 28, 2021, after the market closed, transplant diagnostics company, CareDx, Inc. released Q3 2021 financial results in which the Company disclosed it is being investigated by the U.S. Department of Justice (“DOJ”) related to its kidney testing and phlebotomy services. The Company is also being investigated by the U.S. Securities and Exchange Commission (“SEC”) for similar issues as well as certain accounting and public reporting practices, and the Company received an information request from an unnamed state agency.
Shares of CareDx, Inc (NASDAQ: CDNA) declined from $96.84 per share in June 2021, to as low as $40.31 per share on December 14, 2021.
Those who purchased shares of CareDx, Inc (NASDAQ: CDNA) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation for Long-Term Investors in shares of CareDx, Inc (NASDAQ: CDNA) over possible Wrongdoing here
News-ID: 2502429 • Views: …
More Releases from Shareholders Foundation
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for CareDx
Transplantation Market Growth, Trends & Forecast 2025 | Top key players - CareDx …
Transplantation Market, as analyzed in the study by DataM Intelligence, presents a detailed overview of the industry with in-depth insights, historical data, and key statistics. The report thoroughly examines market dynamics, competitive strategies, and major players, highlighting their product lines, pricing structures, financials, growth plans, and regional outreach.
The Transplantation Market is expected to grow at a CAGR of 9.2% during the forecasting period 2024-2031.
Get a Free Sample PDF Of This…
Organ Care System Market May See Big Move: OCS Heart, Eurosets, CareDx
HTF Market Intelligence published a new research document of 150+pages on Organ Care System Market Insights, to 2030" with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Organ Care System market was mainly driven by the increasing R&D spending by leading and emerging player, however latest scenario and economic…
Investigation announced for Long-Term Investors in CareDx, Inc (NASDAQ: CDNA) ov …
An investigation was announced for current long-term investors in shares of CareDx, Inc (NASDAQ: CDNA) concerning potential breaches of fiduciary duties by certain directors and officers of CareDx, Inc.
Investors who are current long term investors in CareDx, Inc (NASDAQ: CDNA) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
NASDAQ: CDNA Investor Notice: Lawsuit alleges Misleading Statements by CareDx, I …
An investor, who purchased shares of CareDx, Inc (NASDAQ: CDNA), filed a lawsuit over alleged violations of Federal Securities Laws by CareDx, Inc.
Investors who purchased shares of CareDx, Inc (NASDAQ: CDNA) have certain options and for certain investors are short and strict deadlines running. Deadline: July 22, 2022. NASDAQ: CDNA investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
San Francisco, CA based CareDx, Inc. discovers,…
Investigation announced for Investors in CareDx, Inc (NASDAQ: CDNA) shares
CareDx, Inc is under investigation over potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of CareDx, Inc (NASDAQ: CDNA), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of CareDx, Inc (NASDAQ: CDNA) concerning whether a series of statements by CareDx,…
Investigation announced for Investors in CareDx, Inc (NASDAQ: CDNA) over potenti …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at CareDx, Inc.
Investors who purchased shares of CareDx, Inc (NASDAQ: CDNA) have certain options. Please contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain CareDx, Inc (NASDAQ: CDNA officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
Brisbane,…
